Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Kamada is a global biopharmaceutical company based in Israel, focused on the development and manufacturing of specialized plasma-derived protein therapeutics. The company provides innovative treatment solutions for rare diseases, leveraging its extensive expertise in the biopharmaceutical industry.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Kamada is scheduled to report its next quarterly earnings on 08/19/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Kamada last reported quarterly earnings on 5/13/2026 (Q2 2026). Earnings per share (EPS) came in at 0.27 ILS.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.